-
Mashup Score: 68New funding for development of world's first lung cancer vaccine | - 1 month(s) ago
Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to
Source: www.ox.ac.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0Prime Time: Prime Ministers - 5 month(s) ago
Ranking Prime Ministers, one podcast at a time
Source: shows.acast.comCategories: General Medicine News, Oncologists2Tweet-
Prime Time: Prime Ministers - loving this new podcast. How our politics began, from 6th century Witans onwards. Highly recommended 👏 https://t.co/NDnzYQ3Y3h
-
-
Mashup Score: 1Universal DNA methylation age across mammalian tissues - 9 month(s) ago
Nature Aging – This study identifies and characterizes evolutionarily conserved cytosine methylation patterns related to age across mammals and establishes pan-mammalian epigenetic clocks.
Source: www.nature.comCategories: Latest Headlines, Oncologists2Tweet-
Congratulations to @prof_horvath for this beautiful work mapping Universal DNA methylation age across mammalian tissues | Nature Aging. Nice to see LARP1 as a top hit! @LarPsociety https://t.co/rmbkQbg7ce
-
-
Mashup Score: 7Oxford to launch UK’s first trials unit dedicated to - 10 month(s) ago
Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.
Source: www.ox.ac.ukCategories: Latest Headlines, Oncologists2Tweet-
Oxford to launch UK’s first trials unit dedicated to precision-prevention and early detection studies | University of Oxford https://t.co/02u0xmB8LN
-
-
Mashup Score: 7Multi-cancer blood test shows real promise in NHS study - 11 month(s) ago
The Galleri test revealed the correct site of a tumour 85% of the time in a study with 5,000 patients.
Source: BBC NewsCategories: Latest Headlines, Oncologists2Tweet-
RT @OCTO_Oxford: Our SYMPLIFY study findings published… @OxfordOncology @OxfordCancer @OxPrimaryCare @OCTRUctu https://t.co/cgelMVCPdj
-
-
Mashup Score: 0OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer - PubMed - 11 month(s) ago
CBT-based psychological support provided after chemotherapy did not significantly alter the spontaneously improving trajectory of depression scores at three months but caused a significant improvement in FOP. Our findings call for the routine implementation of FOP support for ovarian cancer patients …
Source: PubMedCategories: Latest Headlines, Oncologists2Tweet-
It is not depression or anxiety and is responsive to counselling/mindfulness/cbt. https://t.co/gIRf5BYdk1
-
-
Mashup Score: 0About MyMelanoma | MyMelanoma - 1 year(s) ago
What is MyMelanoma’s mission?
Source: MyMelanomaCategories: Latest Headlines, Oncologists2Tweet-
If you have melanoma (skin cancer) and want to directly contribute to patient-based research, please check out https://t.co/zGR7IpdShD. You contribute to scientific discovery without leaving your armchair! Brilliant. #curemelanona https://t.co/QiwNj4eGOC
-
-
Mashup Score: 0Cancer Prevention and Early Detection - 2 year(s) ago
This week, our host Jonathan Sackier is joined by David Crosby to discuss prevention and early detection of cancer.
Source: European Medical JournalCategories: Latest Headlines, Oncologists2Tweet-
Very good podcast featuring CRUK’s David Crosby talking about the future of Cancer Prevention and Early Detection. Really worth a listen. https://t.co/9nxIstJfVM
-
-
Mashup Score: 0LARP1 regulates metabolism and mTORC1 activity in cancer - 2 year(s) ago
The protein mammalian target of rapamycin (mTOR) is a master regulator of cell homeostasis. Although mTOR is aberrantly overactivated in 70% ovarian cancers, mTOR cascade inhibitors (such as those blocking the kinase activity of mTOR itself or upstream kinases PI3K/AKT) have demonstrated disappointing activity in ovarian cancer clinical trials. These findings indicate that, despite its pivotal…
Source: bioRxivCategories: Latest Headlines, Oncologists2Tweet-
Nice to see our story in print! LARP1 regulates metabolism and mTORC1 activity in cancer https://t.co/mTdEY5mrbL
-
-
Mashup Score: 0Athena SWAN – Women in Focus Article: Dame Louise Richardson - 2 year(s) ago
Dame Louise Richardson is the Vice-Chancellor of the University of Oxford and is a Professor of International Relations. In 2023, she will be departing Oxford to take up a new position as President of New York’s Carnegie Foundation. In this interview, Prof Sarah Blagden hears how Louise’s rural upbringing and passion for academic pursuit has led to a rich and varied international career. A young…
Source: www.oncology.ox.ac.ukCategories: Latest Headlines, Oncologists2Tweet-
Athena SWAN – Women in Focus Article: Dame Louise Richardson https://t.co/txMvTTcCaD
-
A fab collaboration between Oxford and UCL/Crick. @CharlesSwanton @drmaiseb @kevlitchfield @MariamJHanjani discovered neoantigens, tim_tje designed vaccine, @ZinaidaDedeic validated it for trial @OCTO_Oxford https://t.co/kp3LUmei2t